Table 2.
Time (min) | Control | NE28 | NER7 | NER14 |
---|---|---|---|---|
0 | 104.0 ± 2.99 | 105.4 ± 12.37 | 85.8 ± 8.79 | 109.5 ± 4.37 |
15 | 81.5 ± 5.75 (-21.6 %) | 91.8 ± 13.14 (-12.9 %) | 29.0 ± 4.48 (-66.2 %) | 86.3 ± 10.01 (-21.2 %) |
30 | 52.7 ± 8.67 (-49.4 %) | 74.6 ± 12.65 (-29.2 %) | 32.4 ± 3.50 (-62.2 %) | 62.3 ± 13.33 (-43.2 %) |
60 | 49.5 ± 8.98 (-52.4 %) | 74.8 ± 13.09 (-29.0 %) | 31.0 ± 2.65 (-63.9 %) | 48.0 ± 13.03 (-56.2 %) |
120 | 47.5 ± 10.12 (-54.3 %) | 85.0 ± 17.68 (-19.4 %) | 29.3 ± 4.87 (-65.9 %) | 47.5 ± 13.25 (-56.6 %) |
180 | 67.0 ± 6.40 (- 35.6 %) | 81.6 ± 15.20 (-22.6 %) | 28.0 ± 4.81 (-67.4 %) | 67.0 ± 6.00 (38.8 %) |
Data presented as mean ± SEM (n = 6 per group; units – mg/dl). Values in parenthesis represent percent change in blood glucose level relative to 0 min after insulin challenge.